AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 80 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $6 | -71.4% | 11,900 | -55.3% | 0.00% | -50.0% |
| Q4 2022 | $21 | -99.8% | 26,600 | +53.8% | 0.00% | +100.0% |
| Q3 2022 | $10,000 | +400.0% | 17,300 | +6.1% | 0.00% | – |
| Q2 2022 | $2,000 | -89.5% | 16,300 | -39.2% | 0.00% | -100.0% |
| Q1 2022 | $19,000 | +90.0% | 26,800 | +41.1% | 0.00% | – |
| Q4 2021 | $10,000 | +400.0% | 19,000 | +71.2% | 0.00% | – |
| Q2 2021 | $2,000 | -71.4% | 11,100 | -38.0% | 0.00% | – |
| Q1 2021 | $7,000 | +133.3% | 17,900 | +46.7% | 0.00% | – |
| Q3 2020 | $3,000 | -75.0% | 12,200 | -44.3% | 0.00% | -100.0% |
| Q2 2020 | $12,000 | -98.4% | 21,900 | -94.0% | 0.00% | -98.0% |
| Q1 2020 | $748,000 | – | 365,800 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,498,838 | $22,889,355 | 11.72% |
| Knoll Capital Management, LLC | 500,000 | $4,580,000 | 7.06% |
| GENDELL JEFFREY L | 5,301,914 | $48,565,532 | 4.55% |
| COWEN AND COMPANY, LLC | 3,732,778 | $34,192,246 | 4.02% |
| Tri Locum Partners LP | 1,327,097 | $12,156,209 | 3.70% |
| Samsara BioCapital, LLC | 1,409,409 | $12,910,186 | 2.67% |
| Altium Capital Management LP | 500,000 | $4,580,000 | 2.54% |
| Vivo Capital, LLC | 3,761,438 | $34,454,772 | 2.39% |
| RTW INVESTMENTS, LP | 5,741,939 | $52,596,161 | 1.10% |
| Knott David M Jr | 291,113 | $2,667 | 1.05% |